VEXAS Syndrome: A Newly Recognized Entity to Consider in Systemic Disease-Associated Interstitial Lung Disease



Síndrome VEXAS: una entidad recientemente reconocida a considerar en la enfermedad pulmonar intersticial asociada a enfermedad sistémica

VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a recently described hemato-inflammatory disorder caused by somatic mutations in the UBA1 gene, associated with systemic inflammation and myelodysplastic syndromes. Pulmonary involvement is increasingly recognized but remains underdiagnosed. We report a 66-year-old man with rheumatoid arthritis and low-risk myelodysplastic syndrome, evaluated for suspected interstitial lung disease. High-resolution computed tomography (HRCT) showed a probable usual interstitial pneumonia (UIP) pattern with radiological progression. Pulmonary function tests revealed mild airflow obstruction and diffusion impairment, without clear functional progression. A somatic UBA1 mutation confirmed VEXAS syndrome. After multidisciplinary discussion, no antifibrotic therapy was initiated due to the absence of clinically significant functional decline and the suspected inflammatory/hematologic origin of lung involvement. A watchful waiting strategy with close follow-up was adopted, and azacitidine was initiated. This case highlights the importance of considering VEXAS syndrome in interstitial lung disease with systemic features, particularly in the presence of cytopenias.

Enlazar con artículo